Odds, risks and appropriate diagnosis of gestational diabetes-Reference-Cited by-同舟云学术

Odds, risks and appropriate diagnosis of gestational diabetes

Published:2015-04 Issue:6 Volume:202 Page:309-311
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

McIntyre H David¹,Dyer Alan R²,Metzger Boyd E²

Affiliation:

1. Mater Medical Research Institute, University of Queensland, Brisbane, QLD.

2. Northwestern University, Chicago, Ill, USA.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja14.01341

Reference19 articles.

1. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy

2. Comment on d'Emden. Do the new threshold levels for the diagnosis of gestational diabetes mellitus correctly identify women at risk?;Metzger BE;Diabetes Care 2014,2014

3. Reassessment of the new diagnostic thresholds for gestational diabetes mellitus: an opportunity for improvement

4. How to make clinical decisions from statistics

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new mathematical mixed effect model was used for analysing the influencing factors of hypoglycaemia of newborns from women with gestational diabetes mellitus;Journal of Obstetrics and Gynaecology;2022-04-26

2. Underestimation of risk for large babies in rural and remote Australia: Time to change plasma glucose collection protocols;Journal of Clinical & Translational Endocrinology;2021-03

3. Variations in the Prevalence of Gestational Diabetes Mellitus With Remote Testing and a Pragmatic Solution to Improve Accuracy;Diabetes Care;2020-11-09

4. Exploring women’s priorities for the potential consequences of a gestational diabetes diagnosis: A pilot community jury;Health Expectations;2020-02-23

5. Diet and Nutritional Interventions with the Special Role of Myo-Inositol in Gestational Diabetes Mellitus Management. An Evidence-Based Critical Appraisal;Current Pharmaceutical Design;2019-09-27